Company: OBA
Filing Date: 2025-06-05
Form Type: S-1
Source: 0001213900-25-051650
Chunk: 3

Company: Oxley Bridge Acquisition Ltd
Filing Date: 2025-06-05
Form: S-1
Chunk 3
---
 combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold in this offering without our prior consent. However, we would not be restricting our shareholders’ ability to vote all of their shares (including all shares held by those shareholders that hold more than 15% of the shares sold in this offering) for or against our initial business combination. See “Summary — The Offering — Limitation on redemption rights of shareholders holding 15% or more of the shares sold in this offering if we hold shareholder vote” on page 37 for further discussion on certain limitations on redemption rights. Our sponsor, Oxley Bridge Holdings LLC, and Cantor Fitzgerald & Co., the representative of the underwriters, have committed to purchase an aggregate of 6,400,000 private placement warrants (whether or not the underwriters’ over - allotmentoption is exercised), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $6,400,000 in the aggregate (whether or not the underwriters’ over - allotmentoption is exercised), in a private placement that will close simultaneously with the closing of this offering. Of those 6,400,000 private placement warrants (whether or not the underwriters’ over - allotmentoption is exercised), our sponsor has agreed to purchase 4,200,000 private placement warrants (whether or not the underwriters’ over - allotmentoption is exercised) and Cantor Fitzgerald & Co. has agreed to purchase 2,200,000 private placement warrants. Each private placement warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. Seven institutional investors (none of which are affiliated with any member of our management, our sponsor or any other investor), which we refer to as the “non -managingsponsor investors” throughout this prospectus, have expressed an interest to indirectly purchase, through the purchase of non -managingsponsor membership interests, an aggregate of 3,150,000 private placement warrants at a price of $1.00 per warrant